Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the disclosure pertaining to approval of the Composite Scheme of Arrangement by the Board of Directors of the Company at its meeting held on October 25, 2019. We wish to inform you that the Hon''ble National Company Law Tribunal, Allahabad Bench ('NCLT') has, by its Order dated December 23, 2020, sanctioned the Composite Scheme of Arrangement under Sections 230 to 232 read with Section 66 and other applicable provisions of the Companies Act, 2013 amongst HSB Corporate Consultants Private Limited, Jubilant Stock Holding Private Limited, SSB Consultants & Management Services Private Limited, JCPL Life Science Ventures and Holdings Private Limited, JSPL Life Science Services and Holdings Private Limited, Jubilant Life Sciences Limited and Jubilant Ingrevia Limited and their respective shareholders and creditors. We enclose herewith copy of the order as available on the website of NCLT. We request you to take the same on record. (As per BSE Announcement Dated on 24/12/2020) We refer to our letter dated December 24, 2020 regarding pronouncement of order by the National Company Law Tribunal ('NCLT'), Allahabad Bench on the captioned matter. We wish to inform you that the Company has today received Formal Order from NCLT. Copy of the said Order is enclosed herewith. We request you to take the same on record. (AS Per BSE Announcement Dated on 07.01.2021) Outcome of the Restructuring Committee Meeting held on January 8, 2021 - Allotment of Shares pursuant to the Composite Scheme of Arrangement. (As per BSE Announcement Dated on 08/01/2021) Outcome of the Restructuring Committee Meeting held on January 18, 2021 - Allotment of Shares pursuant to the Composite Scheme of Arrangement (As Per BSE Announcement dated on 18.01.2021) We wish to inform you that upon Scheme coming into effect and in consideration of the transfer and vesting of the Life Science Ingredients Undertaking from the Company into Jubilant Ingrevia Limited in terms of the Scheme, the Equity Shareholders of the Company whose names are recorded in the Register of Members and records of the Depositories as members of the Company as on the Record Date i.e. February 5, 2021 will be entitled for allotment of 1 (one) equity share of Jubilant Ingrevia Limited for every 1 (one) equity share held in Jubilant Life Sciences Limited. (As per BSE Announcement Dated on 21/01/2021) In continuation of our letter dated January 21, 2021, we enclose copies of the advertisements published on January 22, 2021 in MINT (English) and HINDUSTAN (Hindi) with respect to the Notice of Record Date pursuant to the Composite Scheme of Arrangement amongst HSB Corporate Consultants Private Limited ('Transferor Company 1'), Jubilant Stock Holding Private Limited ('Transferor Company 2'), SSB Consultants & Management Services Private Limited ('Transferor Company 3'), JCPL Life Science Ventures and Holdings Private Limited ('Transferor Company 4'), JSPL Life Science Services and Holdings Private Limited ('Transferor Company 5') collectively, the 'Transferor Companies'], Jubilant Life Sciences Limited ('Demerged Company/ Transferee Company') and Jubilant Ingrevia Limited ('Resulting Company' - name of Jubilant LSI Limited changed to Jubilant Ingrevia Limited) and their respective shareholders and creditors. (As per BSE Announcement Dated on 22/01/2021) Trading Members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement (for Demerger) approved by the Hon'ble National Company Law Tribunal, Allahabad Bench (NCLT), Jubilant Life Sciences Limited has fixed the Record Date for the purpose of determining entitlement of the shareholders of the Company, as per details given below: COMPANY NAME CODE Jubilant Life Sciences Limited -530019 RECORD DATE 5/2/2021 PURPOSE As per Composite Scheme of Arrangement sanctioned by the Hon'ble National Company Law Tribunal, Allahabad Bench (NCLT), between, HSB Corporate Consultants Private Limited (Transferor Company 1'), Jubilant Stock Holding Private Limited (Transferor Company 2'), SSB Consultants & Management Services Private Limited (Transferor Company 3'), JCPL Life Science Ventures and Holdings Private Limited (Transferor Company 4'), JSPL Life Science Services and Holdings Private Limited (Transferor Company 5') [collectively, the Transferor Companies'], Jubilant Life Sciences Limited (Demerged Company/ Transferee Company') and Jubilant Ingrevia Limited (Resulting Company' - name of Jubilant LSI Limited changed to Jubilant Ingrevia Limited) and their respective shareholders and creditors - Upon the coming into effect of the aforesaid Scheme and in consideration of the transfer of the Life Science Ingredients Undertaking of Jubilant Life Sciences Limited into Jubilant Ingrevia Limited; Jubilant Ingrevia Limited shall issue and allot Equity Shares to the shareholders of Jubilant Life Sciences Limited. Limited in the following proportion: '1 fully paid up equity share of Re. 1/- each fully paid up of Jubilant Ingrevia Limited shall be issued and allotted for every 1 fully paid up equity share of Re. 1/- each fully paid up held in Jubilant Life Sciences Limited.' EX-ENTITLEMENT FROM DATE & SETT. NO. 04/02/2021 DR-214/2020-2021 Note: Pursuant to SEBI Circular No. SEBI/Cir/ISD/1/2010 dated November 2, 2010, Trading members are hereby informed that the trading in the equity shares of the aforesaid company shall be transferred from A' group to T' group w.e.f. February 04, 2021 and pursuant to SEBI Circular No. CIR/MRD/DP/01/2012 dated January 20, 2012; the aforesaid scrip shall be a part of Call Auction in Pre-open Session on February 04, 2021. Subject to compliance with requisite formalities, the shares of Resulting company i.e. Jubilant Ingrevia Limited will be listed on BSE Limited. (As Per BSE Notice Dated on 29.01.2021)